COGENTIN

This brand name is authorized in Singapore, United States

Active ingredients

The drug COGENTIN contains one active pharmaceutical ingredient (API):

1 Benzatropine
UNII WMJ8TL7510 - BENZTROPINE MESYLATE

Benzatropine possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism.

Read about Benzatropine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COGENTIN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04AC01 Benzatropine N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AC Ethers of tropine or tropine derivatives
Discover more medicines within N04AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: SG Health Sciences Authority Identifier(s): 05387P
Country: US FDA, National Drug Code Identifier(s): 76478-611

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.